View Author
expression octreotide treatment octreotide lar edema macular edema somatostatin macular uveiti tnf-a receptor patient episode octreotide lar treatment rpe cells fcrn expression fc receptor level month fcrn protein expression ophthalmol study protein arpe -19 cells analysis effect -19 therapy cystoid macular edema octreotide lar therapy medium case series reduction fcrn mrna disease snellen macular edema reduction acuity rotterdam serum somatostatin receptors calf serum factor control downregulated rpe medium household gene abl van hagen pm fcrn mrna expression tumour necrosis factor epithelial flammatory outcome response ophthalmology fi ndings pigment epithelium -29 antibody injection retina stimulation 53105 cells /well goldmannewitmer coef ficient group.bmj.com laboratory science duration dal monte m 50 ng /ml success rotterdam eye hospital flammation recurrence signi cystoid transcript analog tissue hagen 20 episodes cme reduction
2 Most Recent Publications
|
The neonatal Fc receptor is expressed by human retinal pigment epithelial cells and is downregulated by tumour necrosis factor-alpha
(Article)
Van Bilsen, K. Hagen, P.M. van Bastiaans, J. Meurs, J.C. van Missotten, T. Kuijpers, R.W.A.M. Hooijkaas, H. Dingjan, G.M. Baarsma, G.S. Dik, W.A. |
2011-06-01
|
|
Octreotide Long-Acting Repeatable for the Treatment of Chronic Macular Edema in Uveitis
(Article)
Missotten, T. Laar, J.A.M. van Loos, T.L. van der Daele, P.L.A. van Kuijpers, R.W.A.M. Baarsma, G.S. Hagen, P.M. van |
2007-12-01
|
